Nephros Inc.

165 articles with Nephros Inc.

• Nephros Inc. Announces Date of its 2012 Annual Meeting of Stockholders

  2/13/2012

• Nephros Inc. Receives Euro 750,000 Payment from Bellco S.r.l.

  1/18/2012

• Nephros Inc. Engages Joseph S. Cervia, M.D. as Strategic Consultant

  11/22/2011

• Nephros Inc. Reports Third Quarter 2011 Financial Results

  11/15/2011

• Nephros Inc. Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System

  11/11/2011

• Nephros Inc. Post-Effective Amendment No. 2 to Registration Statement Declared Effective

  10/19/2011

• Nephros Inc. Reports Second Quarter 2011 Financial Results

  8/16/2011

• Nephros Inc. Files 510(k) Application for Hemodiafiltration System

  8/12/2011

• Nephros Inc. Provides Corporate Update

  7/27/2011

• Nephros Inc. Receives 510k Approval to Market Additional Ultrafiltration Products

  7/22/2011

• Nephros Inc. and Bellco S.r.l. Announce License Agreement for Mid-Dilution Dialysis Products

  6/27/2011

• Nephros Inc. Reports First Quarter 2011 Financial Results

  5/17/2011

• Nephros Inc. Receives Approval to Market Dual Stage Ultrafilters in Canada

  5/12/2011

• Nephros Inc. Reports 2010 Fourth Quarter and Full Year Financial Results

  3/30/2011

• Nephros Inc. Announces Split Adjusted Trade Date

  3/16/2011

• Nephros Inc. Announces Completion of Reverse Stock Split

  3/14/2011

• Nephros Inc. Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions

  3/11/2011

• Nephros Inc. Announces $3.2 Million Financing Through Completion of Rights Offering and Private Placement Transactions

  3/7/2011

• Nephros Inc. Extends Rights Offering

  3/1/2011

• Nephros Inc. Rights Offering Registration Statement Declared Effective

  2/1/2011